Orca Bio Stock

orcabio.comBioTechFounded: 2016Funding to Date: $291.19MM

Orca Bio is the developer of high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.

Buy or sell Orca Bio stock

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Orca Bio.

Register Today

Orca Bio investors also invested in these private companies

Lightspeed Venture Partners

Ripple, Rubrik, DataStax, ThoughtSpot, Docker, YugaByte, Outschool, Orca Bio, TripActions, Cameo

DCVC

8VC

Sila Nanotechnologies, The Boring Company, YugaByte, Orca Bio, Vercel, Blend Labs, Cityblock Health, Nylas, Qualia, Airbyte

Team

Management Team

Ivan Dimov Ph.D

Co-Founder & Chief Executive Officer

Jeroen Bekaert

Chief Operating Officer

Nathaniel Fernhoff Ph.D

Co-Founder & Chief Science Officer

Dan Kirby

Chief Commercial Officer

Board Members

Alex Kolicich

8VC

Jonathan MacQuitty Ph.D

Lightspeed Venture Partners

Other companies like Orca Bio in the BioTech sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Arsenal Biosciences

Sector

Last Round Est. Valuation

$185MM

Sector

Last Round Est. Valuation

$4.26B

Life Biosciences

Sector

Last Round Est. Valuation

$500MM

Sector

Last Round Est. Valuation

$1.3B

Caris Life Sciences

Sector

Human Longevity

Sector

Last Round Est. Valuation

$50.4MM

Ginkgo Bioworks

Sector

Last Round Est. Valuation

$4.89B

Frequently Asked Questions